Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 25, Topic 5
In Progress

Ventriculostomy Management and Complication Prevention

Lesson Progress
0% Complete
Optimizing Ventriculostomy Management to Prevent Complications

Optimizing Ventriculostomy Management to Prevent Complications

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Lesson Objective

Recommend appropriate strategies for ventriculostomy management to prevent complications and optimize patient outcomes.

1. Standardized CSF Drainage Protocols

Controlled CSF diversion via an external ventricular drain (EVD) maintains intracranial pressure (ICP) within target ranges to prevent cerebral edema, herniation, and secondary injury.

Physiological Rationale for ICP Control

  • Removal of CSF reduces ventricular volume and ICP when autoregulation is impaired.
  • Target adult ICP <20 mmHg (adjust for age or disease).
  • In hyperammonemic or metabolic encephalopathies, early CSF diversion mitigates rapid cerebral edema.

Pressure Transducer Setup

  1. Level at the external auditory meatus (tragus = foramen of Monro reference).
  2. Zero to atmospheric pressure before patient connection.
  3. Re‐level and re‐zero after patient repositioning or bed adjustment.
EVD Transducer Leveling Diagram Illustration showing the correct leveling of an EVD pressure transducer at the external auditory meatus (tragus), corresponding to the Foramen of Monro.
EVD Transducer Leveling
Tragus (EAM)
(Foramen of Monro level)
Pressure Transducer
Zeroed & Leveled
Figure 1: Correct leveling of the EVD pressure transducer to the external auditory meatus (tragus), which approximates the Foramen of Monro.

Continuous vs Intermittent Drainage

  • Continuous: EVD open at preset ICP threshold; steady control but risk of overdrainage.
  • Intermittent: Open only when ICP exceeds threshold; lower overdrainage risk but requires frequent checks.
  • Institutional choice guided by patient stability and resource availability.

Preset Pressure and Volume Limits

  • Common ICP thresholds: 10–20 mmHg.
  • Adult volume limit: ≤20 mL/hour; pediatric limits lower.
  • Monitor hourly CSF output to avoid subdural collections or ventricular collapse.

Documentation Practices

  • Use standardized order sets and flow sheets.
  • Record: reference level, drain setting, hourly output, ICP trends, interventions.
  • Checklist for shift changes and rounding.
Pearl IconA shield with an exclamation mark. Key Pearls
  • Leveling errors of 1 cm H₂O ≈ 0.74 mmHg; misleveling can lead to inappropriate drainage.
  • Continuous drainage may control ICP more tightly but increases manipulation-associated infection risk.

2. Infection Control Measures

Rigorous aseptic technique at insertion and during maintenance is critical to minimize EVD‐associated infections.

Aseptic Insertion (Maximal Barrier Precautions)

  • Full sterile drape, gown, gloves, mask, cap.
  • Pre-procedural skin prep: chlorhexidine if tolerated.
  • Consider single‐dose prophylactic antibiotic (e.g., cefazolin) per institutional protocol.*

Editor’s Note: Specific prophylactic antibiotic regimen, timing, and dosing vary by institution.

Sterile Handling and Dressings

  • Disinfect all access ports with chlorhexidine‐alcohol before CSF sampling or flushing.
  • Change dressings every 48–72 hours or when soiled under sterile conditions.
  • Limit system breaks and minimize port entries.

Catheter Replacement Criteria

  • Do not exchange routinely; increases hemorrhage risk.
  • Replace only for confirmed infection or persistent obstruction unresponsive to conservative measures.

Catheter Material Selection

  • Standard vs antibiotic-impregnated catheters (AICs).
  • AICs elute rifampin/clindamycin to inhibit colonization; consider in high‐risk settings.
  • Monitor for cost and potential antibiotic resistance.

Surveillance for Early Detection

  • Daily assessment: fever, neck stiffness, altered mental status.
  • Routine CSF studies: cell count, glucose, protein, Gram stain; interpret trends.
  • Avoid routine cultures in absence of clinical suspicion to limit false positives.
Pearl IconA shield with an exclamation mark. Clinical Pearl

Most EVD infections occur during device access, not initial placement—prioritize sterile handling for every manipulation.

3. Early Recognition of EVD Malfunction and Infection

Timely identification of device malfunction or infection prevents secondary injury and guides urgent interventions.

Clinical Signs

  • New fever, meningismus, unexplained agitation or decline in Glasgow Coma Scale.
  • Headache or new focal deficits (if patient responsive).

CSF Monitoring

  • Inspect appearance: cloudiness, xanthochromia.
  • Track CSF WBC trends, glucose drop, protein rise.
  • Initiate Gram stain and culture if infection is suspected.

Radiographic Assessment

  • Noncontrast head CT to confirm catheter tip location and exclude hemorrhage or ventricular collapse.
  • Evaluate for new intraventricular or parenchymal bleed.

Troubleshooting Obstruction

  • Blood clot or debris common cause.
  • Gentle saline flush if permitted; avoid high‐pressure injections.
  • Thrombolytics (e.g., urokinase) controversial—check local protocols.

Initial Interventions

  • If infection suspected: remove/exchange catheter under sterile conditions, obtain CSF cultures.
  • Start empiric broad‐spectrum antibiotics covering skin flora and Gram‐negatives (e.g., vancomycin + cefepime).*
  • Consult infectious disease for targeted therapy and intraventricular antibiotic dosing.

Editor’s Note: Empiric antibiotic choices and intrathecal dosing guidelines are institution‐specific and should be detailed in local protocols.

Pearl IconA shield with an exclamation mark. Key Pearl

Early catheter removal and tailored antimicrobial therapy improve outcomes in EVD‐associated meningitis/ventriculitis.

4. Multidisciplinary Care Coordination

Effective EVD management hinges on structured collaboration among neurosurgery, nursing, and pharmacy.

Roles and Responsibilities

  • Neurosurgery: device insertion, troubleshooting, surgical revisions.
  • Nursing: transducer checks, drain maintenance, hourly output documentation.
  • Pharmacy: order verification, antibiotic selection/dosing, compatibility review (intraventricular agents), antimicrobial stewardship.

Communication Tools

  • Use handoff checklists that include EVD settings, recent outputs, complications.
  • Conduct daily interdisciplinary rounds with standardized EVD status report.

Pharmacist Contributions

  • Review EVD order sets for accurate pressure/volume limits.
  • Ensure preservative-free formulations for intraventricular antibiotics.
  • Educate staff on drug–device interactions and safe flushing techniques.

Family and Clinician Education

  • Provide written and verbal guidance on signs of malfunction/infection.
  • Use simulation or bedside demos to reinforce sterile handling basics.
Pearl IconA shield with an exclamation mark. Clinical Pearl

Pharmacist involvement on rounds reduces medication errors related to EVD prescriptions and improves protocol adherence.

5. Weaning and EVD Removal Criteria

Structured weaning protocols and vigilant post‐removal monitoring minimize the risk of rebound intracranial hypertension.

Assessment of Readiness

  • Stable ICP <15 mmHg for ≥24 hours.
  • Neurologic exam at baseline or improving.
  • Radiographic evidence of ventricular size stability.

Weaning Protocols

  • Gradual elevation: raise drain level by 5 cm H₂O every 12–24 hours.
  • Clamp trials: close drain and monitor ICP; resume diversion if ICP >20 mmHg or clinical decline.

Decision Algorithms

  • Tolerates wean → remove EVD.
  • Recurrent elevated ICP → consider permanent shunt or prolonged EVD.
EVD Weaning and Removal Algorithm

Assess Readiness:
Stable ICP, Neuro Exam OK, Vent. Size Stable

Initiate Weaning Protocol
(Gradual Elevation / Clamp Trial)

Tolerates Wean?

No
(Recurrent ↑ICP / Decline)

Consider Permanent Shunt / Prolonged EVD

Yes

Remove EVD

Figure 2: Algorithm for EVD weaning and removal based on patient tolerance and ICP stability.

Post‐Removal Monitoring

  • Hourly neurologic checks for 12 hours, then every 2–4 hours.
  • Repeat head CT if new neurologic changes or persistent headache.
  • Reinstate drainage if ICP rises above threshold or exam worsens.
Pearl IconA shield with an exclamation mark. Key Pearl

Clamp trials that include both ICP monitoring and clinical exam yield the highest predictive value for successful EVD removal.

References

  1. Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury. Neurosurgery. 2017;80(1):6–15.
  2. Smith M. Multimodality neuromonitoring in adult traumatic brain injury: a narrative review. Anesthesiology. 2018;128(2):401–415.
  3. Castillo-Pinto C, Sen K, Gropman A. Neuromonitoring in Rare Disorders of Metabolism. Yale J Biol Med. 2021;94:645–655.
  4. Wendell LC, Khan A, Raser J, et al. Successful management of refractory intracranial hypertension from acute hyperammonemic encephalopathy in a woman with OTC deficiency. Neurocrit Care. 2010;13(1):113–117.
  5. Waisbren SE, Gropman AL, Batshaw ML; Urea Cycle Disorders Consortium. Improving long term outcomes in urea cycle disorders. J Inherit Metab Dis. 2016;39(4):573–584.
  6. Häberle J, Boddaert N, Burlina A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012;7(1):32.
  7. Gropman A. Brain imaging in urea cycle disorders. Mol Genet Metab. 2010;100(Suppl 1):S20–30.
  8. Chock VY, Rao A, Van Meurs KP. Optimal neuromonitoring techniques in neonates with hypoxic ischemic encephalopathy. Front Pediatr. 2023;11:1138062.